Immune function assay (ImmuKnow) as a predictor of allograft rejection and infection in kidney transplantation

Clinical Transplantation

Volumn 27, Issue 4, 2013, Pages

  He, Jun ^a   Li, Yang ^a   Zhang, Hui ^a   Wei, Xudong ^a   Zheng, Hao ^a   Xu, Chao ^a   Bao, Xiaojing ^a   Yuan, Xiaoni ^a   Hou, Jianquan ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

ImmuKnow; Immune monitoring; Infection; Kidney transplantation; Rejection

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CREATININE; TACROLIMUS;

ADULT; ARTICLE; ASSAY; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; FEMALE; GRAFT INFECTION; HUMAN; IMMUNE FUNCTION TEST; IMMUNOASSAY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

IMMUKNOW; IMMUNE MONITORING; INFECTION; KIDNEY TRANSPLANTATION; REJECTION;

ADOLESCENT; ADULT; ALLOGRAFTS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; HUMANS; IMMUNITY, CELLULAR; IMMUNOLOGIC TESTS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84881557647     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12134     Document Type: Article

References (18)

1. De Jonge H, Naesens M, Kuypers DR. New insights into the pharmacokinetics and pharmacodynamics of the calcineurin inhibitors and mycophenolic acid: possible consequences for therapeutic drug monitoring in solid organ transplantation. Ther Drug Monit 2009: 31: 416.
2. Quteineh L, Verstuyft C. Pharmacogenetics in immunosuppressants: impact on dose requirement of calcineurin inhibitors in renal and liver pediatric transplant recipients. Curr Opin Organ Transplant 2010: 15: 601.
3. Keown PA, on behalf of the International Neoral Renal Transplantation Study Group. Randomized, international study of cyclosporine microemulsion absorption profiling in renal transplantation with basiliximab immunoprophylaxis. Am J Transplant 2002: 2: 157.
4. Rovira P, Mascarell L, Truffa-Bachi P. The impact of immunosuppressive drugs on the analysis of T cell activation. Curr Med Chem 2000: 7: 673.
5. Kowalski RJ, Post DR, Mannon RB et al. Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay. Transplantation 2006: 82: 663.
6. Kowalski RJ, Post DR, Schneider MC et al. Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management. Clin Transplant 2003: 17: 77.
7. Cadillo-Chavez R, DE Echegaray S, Santiago-Dephin EA et al. Assessing the risk of infection and rejection in Hispanic renal transplant recipients by means of an adenosine triphosphate release assay. Transplant Proc 2006: 38: 918.
8. Husain S, Raza K, Pilewski JM et al. Experience with immune monitoring in lung transplant recipients: correlation of low immune function with infection. Transplantation 2009: 87: 1852.
9. Huskey J, Gralla J, Wiseman AC. Single time point immune function assay (ImmuKnowTM) testing does not aid in the prediction of future opportunistic infections or acute rejection. Clin J Am Soc Nephrol 2011: 6: 423.
10. Torio A, Fernández EJ, Montes-Ares O et al. Lack of association of immune cell function test with rejection in kidney transplantation. Transpl Proc 2011: 43: 2168.
11. Xue F, Zhang J, Han L et al. Immune cell functional assay in monitoring of adult liver transplantation recipients with infection. Transplantation 2010: 89: 620.
12. Huskey J, Gralla J, Wiseman AC. Use of the Cylex ImmuKnow assay in the prediction of acute rejection or opportunistic infection following kidney transplantation. J Am Soc Nephrol 2008: 19: 9A.
13. Hooper E, Hawkins DM, Kowalski RJ et al. Establishing pediatric immune response zones using the Cylex ImmuKnow assay. Clin Transplant 2005: 19: 834.
14. TM) results in the first year post-transplant and relationship to BK virus infection. Nephrol Dial Transplant 2012: 27: 2565.
15. Schulz-Juergensen S, Burdelski MM, Oellerich M et al. Intracellular ATP production in CD4 + T cells as a predictor for infection and allograft rejection in trough-level guided pediatric liver transplant recipients under calcineurin-inhibitor therapy. Ther Drug Monit 2012: 34: 4.
16. Berglund D, Bengtsson M, Biglarnia A, et al. Screening of mortality in transplant patients using an assay for immune function. Transpl Immunol 2011: 24: 246.
17. Serban G, Whittaker V, Fan J et al. Significance of immune cell function monitoring in renal transplantation after thymoglobulin induction therapy. Hum Immunol 2009: 70: 882.
18. Akhlaghi F, Gohh RY. The level of ATP production in mitogen-stimulated CD4+ lymphocytes is independent of the time of ingestion of immunosuppressive agents. Ther Drug Monit 2010: 32: 116.